Eradication of CML stem cells

por Carter, Bing Z., Andreeff, Michael
Publicado 2016

Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang

por Zhou, Hong-Sheng, Carter, Bing Z., Andreeff, Michael
Publicado 2016

Molecular Mechanisms of Ferroptosis and Updates of Ferroptosis Studies in Cancers and Leukemia

por Akiyama, Hiroki, Carter, Bing Z., Andreeff, Michael, Ishizawa, Jo
Publicado 2023

Application of machine learning methods in clinical trials for precision medicine

por Wang, Yizhuo, Carter, Bing Z, Li, Ziyi, Huang, Xuelin
Publicado 2022

Expression of parafibromin in major renal cell tumors

por Cui, C., Lal, P., Master, S., Ma, Y., Baradet, T., Bing, Z.
Publicado 2012

Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways

por Chen, Qinwei, Deng, Suqi, Deng, Manman, Shi, Yuanfei, Zhong, Mengya, Ding, Lihong, Jiang, Yuelong, Zhou, Yong, Carter, Bing Z., Xu, Bing
Publicado 2022

Inhibition of menin, BCL-2, and FLT3 combined with a hypomethylating agent cures NPM1/FLT3-ITD/-TKD mutant acute myeloid leukemia in a patient-derived xenograft model

por Carter, Bing Z., Mak, Po Yee, Tao, Wenjing, Ostermann, Lauren B., Mak, Duncan H., Ke, Baozhen, Ordentlich, Peter, McGeehan, Gerard M., Andreeff, Michael
Publicado 2023

miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathways

por Fang, Zhi Hong, Wang, Si Li, Zhao, Jin Tao, Lin, Zhi Juan, Chen, Lin Yan, Su, Rui, Xie, Si Ting, Carter, Bing Z, Xu, Bing
Publicado 2016

Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and re-sensitizes acute myeloid leukemia to BCL-2 inhibition

por Carter, Bing Z., Mak, Po Yee, Tao, Wenjing, Warmoes, Marc, Lorenzi, Philip L., Mak, Duncan, Ruvolo, Vivian, Tan, Lin, Cidado, Justin, Drew, Lisa, Andreeff, Michael
Publicado 2020

Combined inhibition of MDM2 and BCR-ABL1 tyrosine kinase targets chronic myeloid leukemia stem/progenitor cells in a murine model

por Carter, Bing Z., Mak, Po Yee, Mu, Hong, Wang, Xiangmeng, Tao, Wenjing, Mak, Duncan H., Dettman, Elisha J., Cardone, Michael, Zernovak, Oleg, Seki, Takahiko, Andreeff, Michael
Publicado 2020

Combining triptolide with ABT-199 is effective against acute myeloid leukemia through reciprocal regulation of Bcl-2 family proteins and activation of the intrinsic apoptotic pathw...

por Shi, Yuan-Fei, Liu, Long, He, Ling-Li, Ye, Jing, Lin, Zhi-Juan, Yuan, De-Lin, Deng, Man-Man, Fang, Zhi-Hong, Carter, Bing Z., Xu, Bing
Publicado 2020

Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34(+) proliferating and quiescent chronic myeloid leukemia blast c...

por Carter, Bing Z., Mak, Po Yee, Mak, Duncan H., Ruvolo, Vivian R., Schober, Wendy, McQueen, Teresa, Cortes, Jorge, Kantarjian, Hagop M., Champlin, Richard E., Konopleva, Marina, Andreeff, Michael
Publicado 2015

Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFκB/IL1β signaling network

por Carter, Bing Z., Mak, Po Yee, Chen, Ye, Mak, Duncan H., Mu, Hong, Jacamo, Rodrigo, Ruvolo, Vivian, Arold, Stefan T., Ladbury, John E., Burks, Jared K., Kornblau, Steven, Andreeff, Michael
Publicado 2016

Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms

por Lan, Xiaoying, Zhao, Chong, Chen, Xin, Zhang, Peiquan, Zang, Dan, Wu, Jinjie, Chen, Jinghong, Long, Huidan, Yang, Li, Huang, Hongbiao, Carter, Bing Z., Wang, Xuejun, Shi, Xianping, Liu, Jinbao
Publicado 2016

Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia

por Jiang, Xuejie, Jiang, Ling, Cheng, Jiaying, Chen, Fang, Ni, Jinle, Yin, Changxin, Wang, Qiang, Wang, Zhixiang, Fang, Dan, Yi, Zhengshan, Yu, Guopan, Zhong, Qingxiu, Carter, Bing Z., Meng, Fanyi
Publicado 2021

The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patients

por Jiang, Xuejie, Wang, Zhixiang, Ding, Bingjie, Yin, Changxin, Zhong, Qingxiu, Carter, Bing Z., Yu, Guopan, Jiang, Ling, Ye, Jieyu, Dai, Min, Zhang, Yu, Liang, Shuang, Zhao, Qingxia, Liu, Qifa, Meng, Fanyi
Publicado 2015

ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia

por Ebner, Jessica, Schmoellerl, Johannes, Piontek, Martin, Manhart, Gabriele, Troester, Selina, Carter, Bing Z., Neubauer, Heidi, Moriggl, Richard, Szakács, Gergely, Zuber, Johannes, Köcher, Thomas, Andreeff, Michael, Sperr, Wolfgang R., Valent, Peter, Grebien, Florian
Publicado 2023

Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms

por Chen, Xin, Shi, Xianping, Zhao, Chong, Li, Xiaofen, Lan, Xiaoying, Liu, Shouting, Huang, Hongbiao, Liu, Ningning, Liao, Siyan, Zang, Dan, Song, Wenbin, Liu, Quentin, Carter, Bing Z., Dou, Q. Ping, Wang, Xuejun, Liu, Jinbao
Publicado 2014

Bcl-2 inhibition combined with PPARα activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemia

por Xie, Chendi, Zhou, Hui, Qin, Dongmei, Zheng, Huijian, Tang, Yuanfang, Li, Wenjuan, Zhou, Jie, Liu, Long, Yu, Xinxin, Duan, Hongpeng, Zhou, Yong, Li, Zhifeng, Fang, Zhihong, Luo, Yiming, Carter, Bing Z., Xu, Bing, Zha, Jie
Publicado 2023

Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics

por Carter, Bing Z., Mak, Po Yee, Tao, Wenjing, Ayoub, Edward, Ostermann, Lauren B., Huang, Xuelin, Loghavi, Sanam, Boettcher, Steffen, Nishida, Yuki, Ruvolo, Vivian, Hughes, Paul E., Morrow, Phuong K., Haferlach, Torsten, Kornblau, Steven, Muftuoglu, Muharrem, Andreeff, Michael
Publicado 2023